Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

The global Liquid Biopsy Market is experiencing significant growth, driven by increasing cancer prevalence, advancements in ...

With an at least $60 billion total addressable market, the liquid biopsy sector offers abundant opportunity for multiple companies to swim to the top. The six largest companies in the pool have just ...

Updated results of an Australian trial which used liquid biopsies to guide colon cancer treatment has confirmed no compromise ...

Dynamic Biopsy non-invasively analyses dynamic biological processes within a specific organ or tissue to assess its health ...

While liquid biopsies can offer significant advantages, there are critical factors to assess the quality of these solutions ...